Factors Associated with PrEP Support and Disclosure Among YMSM and Transgender Individuals Assigned Male at Birth in Chicago.


Journal

AIDS and behavior
ISSN: 1573-3254
Titre abrégé: AIDS Behav
Pays: United States
ID NLM: 9712133

Informations de publication

Date de publication:
Oct 2019
Historique:
pubmed: 23 6 2019
medline: 18 12 2019
entrez: 23 6 2019
Statut: ppublish

Résumé

Pre-exposure prophylaxis (PrEP) is one of the best biomedical HIV prevention tools available. However, uptake, particularly in communities of men who have sex with men (MSM) and transgender individuals assigned male at birth (AMAB), remains low. Further, the role of an individual's social support structure on PrEP uptake and adherence remains largely understudied. Understanding MSM and AMAB transgender individuals' perceptions of PrEP use as well as support and patterns of disclosure of (or intent to disclose) their PrEP status may offer key insights into how best to improve uptake in vulnerable communities. Further, the influence of one's social connections on other factors, such as perceptions of and conversations about PrEP deserves attention as well, as these factors may be key to improved knowledge and uptake. Therefore, we assessed perceptions of PrEP use, disclosure of or intent to disclose PrEP status, and social support and associated factors among a cohort of MSM and AMAB transgender individuals in a large Midwestern city. Results demonstrated that, among those not taking PrEP, bisexual participants and those unsure of their sexual identity were less likely to be comfortable with the idea of disclosing PrEP use were they ever to start taking it. Encouragingly however, we found that individuals who reported disclosing their PrEP status had high rates of support among friends and relatives. We also observed that knowing someone else who was on PrEP was associated with increased likelihood of discussing PrEP with one's medical provider, as was increased age. Other findings and implications for research, policy, and practice are discussed within.

Identifiants

pubmed: 31228025
doi: 10.1007/s10461-019-02561-1
pii: 10.1007/s10461-019-02561-1
pmc: PMC6942489
mid: NIHMS1043569
doi:

Substances chimiques

Anti-HIV Agents 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

2749-2760

Subventions

Organisme : NIDA NIH HHS
ID : U01 DA036939
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR001422
Pays : United States
Organisme : NIDA NIH HHS
ID : U01DA036939
Pays : United States

Références

J Int AIDS Soc. 2016 Jun 13;19(1):20903
pubmed: 27302837
Health Educ Behav. 2016 Apr;43(2):217-25
pubmed: 27037286
AIDS Care. 2017 Nov;29(11):1351-1358
pubmed: 28286983
AIDS Patient Care STDS. 2017 Apr;31(4):196-204
pubmed: 28414261
AIDS Behav. 2018 Nov;22(11):3637-3644
pubmed: 29728949
J Acquir Immune Defic Syndr. 2013 Jul;63 Suppl 2:S122-9
pubmed: 23764623
AIDS Educ Prev. 2015 Apr;27(2):112-25
pubmed: 25915697
J Acquir Immune Defic Syndr. 2012 Apr 15;59(5):463-8
pubmed: 22267018
Lancet HIV. 2015 Dec;2(12):e512-9
pubmed: 26614965
J Acquir Immune Defic Syndr. 2017 Jan 1;74(1):15-20
pubmed: 27552158
Prev Sci. 2017 Jul;18(5):505-516
pubmed: 28101813
AIDS Behav. 2013 Jul;17(6):2173-9
pubmed: 23128980
Health Psychol. 2004 Mar;23(2):207-18
pubmed: 15008666
J Adolesc Health. 2017 May;60(5):549-555
pubmed: 28132744
AIDS Patient Care STDS. 2010 Nov;24(11):689-91
pubmed: 20863247
AIDS. 2015 Apr 24;29(7):837-45
pubmed: 25730508
Psychol Methods. 2000 Mar;5(1):44-63
pubmed: 10937322
J Behav Med. 2003 Aug;26(4):315-32
pubmed: 12921006
AIDS Behav. 2017 May;21(5):1236-1246
pubmed: 28108878
AIDS Behav. 2018 Sep;22(9):3044-3056
pubmed: 29789985
Lancet HIV. 2015 Dec;2(12):e502-3
pubmed: 26614960
Sex Transm Infect. 2017 Feb;93(1):52-55
pubmed: 27356041
J Acquir Immune Defic Syndr. 2016 Feb 1;71(2):200-6
pubmed: 26761520
AIDS Patient Care STDS. 2018 Jan;32(1):24-30
pubmed: 29185801
AIDS Behav. 2017 Sep;21(9):2774-2783
pubmed: 28035497
Am J Public Health. 2010 Dec;100(12):2426-32
pubmed: 20966378
Int J STD AIDS. 2018 Mar;29(4):375-381
pubmed: 28853676
Prev Sci. 2019 Oct;20(7):1089-1097
pubmed: 30712223
J Urban Health. 2016 Apr;93(2):400-6
pubmed: 27055446
AIDS Patient Care STDS. 2015 Sep;29(9):490-502
pubmed: 26121564
J Acquir Immune Defic Syndr. 2018 Apr 15;77(5):459-466
pubmed: 29280767
AIDS Educ Prev. 2012 Oct;24(5):408-21
pubmed: 23016502
PLoS One. 2016 Jan 12;11(1):e0146513
pubmed: 26756474
AIDS Behav. 2017 May;21(5):1288-1298
pubmed: 27401537
AIDS Patient Care STDS. 2017 Dec;31(12):517-527
pubmed: 29211513
Lancet Infect Dis. 2014 Sep;14(9):820-9
pubmed: 25065857
Am J Public Health. 1991 Feb;81(2):168-71
pubmed: 1990853
N Engl J Med. 2015 Dec 3;373(23):2237-46
pubmed: 26624850
Contemp Clin Trials. 2015 Nov;45(Pt B):244-251
pubmed: 26476286
AIDS Behav. 2017 May;21(5):1376-1382
pubmed: 28238119
AIDS Care. 2013 Aug;25(8):961-7
pubmed: 23252473
J Assoc Nurses AIDS Care. 2016 Mar-Apr;27(2):133-42
pubmed: 26708834
Lancet Infect Dis. 2013 Mar;13(3):214-22
pubmed: 23260128
Biostatistics. 2010 Apr;11(2):373-4
pubmed: 19948745
Hum Genet. 2005 Mar;116(4):272-8
pubmed: 15645181
Curr HIV Res. 2013 Oct;11(7):520-7
pubmed: 24476355
AIDS Patient Care STDS. 2015 Aug;29(8):423-9
pubmed: 26083143

Auteurs

Gregory Phillips (G)

Department of Medical Social Sciences, Northwestern University Feinberg School of Medicine, 625 N Michigan Ave 14-043, Chicago, IL, 60611, USA. glp2@northwestern.edu.

Anand Raman (A)

Department of Medical Social Sciences, Northwestern University Feinberg School of Medicine, 625 N Michigan Ave 14-043, Chicago, IL, 60611, USA.

Dylan Felt (D)

Department of Medical Social Sciences, Northwestern University Feinberg School of Medicine, 625 N Michigan Ave 14-043, Chicago, IL, 60611, USA.

Ying Han (Y)

Department of Medical Social Sciences, Northwestern University Feinberg School of Medicine, 625 N Michigan Ave 14-043, Chicago, IL, 60611, USA.

Brian Mustanski (B)

Department of Medical Social Sciences, Northwestern University Feinberg School of Medicine, 625 N Michigan Ave 14-043, Chicago, IL, 60611, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH